Clinical Trials Directory

Trials / Completed

CompletedNCT02744508

Comparison of Palonosetron Versus Combination of Palonosetron and Dexamethasone for Preventing Postoperative Vomiting in Patients Receiving Fentanyl by Patient-controlled Analgesia After Minor Orthopedic Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
202 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Postoperative nausea and vomiting (PONV) is related with extended hospital day and risk factor of aspiration pneumonia. Postoperative patient controlled intravenous analgesia is related with postoperative nausea and vomiting. Selective 5-HT3 antagonist, Palonosetron, is the most recent medication for prevention of PONV. Purpose of our study is comparison of PONV preventive effect of palonosetron and combination of palonosetron and dexamethasone.

Conditions

Interventions

TypeNameDescription
DRUGpalonosetron
DRUGpalonosetron with dexamethasone

Timeline

Start date
2015-07-24
Primary completion
2017-03-20
Completion
2017-03-20
First posted
2016-04-20
Last updated
2018-06-20

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02744508. Inclusion in this directory is not an endorsement.

Comparison of Palonosetron Versus Combination of Palonosetron and Dexamethasone for Preventing Postoperative Vomiting in (NCT02744508) · Clinical Trials Directory